Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with FMT
JCI Insight
.
2025 Jan 7:e186649.
doi: 10.1172/jci.insight.186649.
Online ahead of print.
Authors
Jing Zeng
1
,
Derrick Zhao
1
,
Grayson Way
1
,
Andrew Fagan
1
,
Michael Fuchs
1
,
Puneet Puri
1
,
Brian C Davis
1
,
Xuan Wang
1
,
Emily C Gurley
1
,
Phillip B Hylemon
1
,
Jian-Gao Fan
2
,
Masoumeh Sikaroodi
3
,
Patrick M Gillevet
1
,
Huiping Zhou
1
,
Jasmohan S Bajaj
1
Affiliations
1
Virginia Commonwealth University and Richmond VA Medical Center, Richmond, United States of America.
2
Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
3
Microbiome Analysis Center, George Mason University, Manassas, United States of America.
PMID:
39773539
DOI:
10.1172/jci.insight.186649
No abstract available
Keywords:
Hepatitis; Hepatology; Innate immunity; Liver cancer; Microbiology.